Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Research article

Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece

George D Katopodis1, Ioanna N Grivea1, Angeliki J Tsantsaridou2, Spyros Pournaras3, Efi Petinaki3 and George A Syrogiannopoulos1*

Author Affiliations

1 Department of Pediatrics, University of Thessaly, Medical School, Biopolis, 411 10 Larissa, Greece

2 Department of Thoracic Surgery, University of Thessaly, Medical School, Biopolis, 411 10 Larissa, Greece

3 Department of Microbiology, University of Thessaly, Medical School, Biopolis, 411 10 Larissa, Greece

For all author emails, please log on.

BMC Infectious Diseases 2010, 10:351  doi:10.1186/1471-2334-10-351

Published: 13 December 2010

Abstract

Introduction

In Greece, fusidic acid and clindamycin are commonly used for the empiric therapy of suspected staphylococcal infections.

Methods

The medical records of children examined at the outpatient clinics or admitted to the pediatric wards of the University General Hospital of Larissa, Central Greece, with community-associated staphylococcal infections from January 2003 to December 2009 were reviewed.

Results

Of 309 children (0-14 years old), 21 (6.8%) had invasive infections and 288 (93.2%) skin and soft tissue infections (SSTIs). Thirty-five patients were ≤30 days of age. The proportion of staphylococcal infections caused by a community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) isolate increased from 51.5% (69 of 134) in 2003-2006 to 63.4% (111 of 175) in 2007-2009 (P = 0.037). Among the CA-MRSA isolates, 88.9% were resistant to fusidic acid, 77.6% to tetracycline, and 21.1% to clindamycin. Clindamycin resistance increased from 0% (2003) to 31.2% (2009) among the CA-MRSA isolates (P = 0.011). Over the 7-year period, an increase in multidrug-resistant CA-MRSA isolates was observed (P = 0.004). One hundred and thirty-one (93.6%) of the 140 tested MRSA isolates were Panton-Valentine leukocidin-positive. Multilocus sequence typing of 72 CA-MRSA isolates revealed that they belonged to ST80 (n = 61), ST30 (n = 6), ST377 (n = 3), ST22 (n = 1), and ST152 (n = 1). Resistance to fusidic acid was observed in ST80 (58/61), ST30 (1/6), and ST22 (1/1) isolates.

Conclusion

In areas with high rate of infections caused by multidrug-resistant CA-MRSA isolates, predominantly belonging to the European ST80 clone, fusidic acid and clindamycin should be used cautiously as empiric therapy in patients with suspected severe staphylococcal infections.